Work

Abstract 3717: Randomized phase II trial of cladribine with or without immediate rituximab for newly diagnosed or previously treated hairy cell leukemia to eliminate minimal residual disease: Interim report

Year: 2010

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am10-3717

Authors: Robert J. Kreitman, Pierre Noel, Constance M. Yuan, Mark Raffeld, Maryalice Stetler-Stevenson

Institutions: National Cancer Institute, National Institutes of Health, National Institutes of Health Clinical Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2329960519

Cites:

Cited by:

Related to: 10